Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11

Affiliations

• ¹ Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Jackson 1115, Boston, MA, USA.
• ² Department of Endocrinology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jie Fang Avenue, Wuhan, 430022, China.
• ³ Center for Computational and Integrative Biology (CCIB), Massachusetts General Hospital, Boston, MA, 02139, USA.
• ⁴ Department of Orthopaedic Surgery, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jie Fang Avenue, Wuhan, 430022, China.
• ⁵ Division of Hematology and Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
• ⁶ Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Jackson 1115, Boston, MA, USA. zduan@mgh.harvard.edu.